title: Osteoarthritis and rheumatoid arthritis: will new data clarify the risk:benefit ratio of cyclooxygenase-2 inhibitors?
authors.forename: Manfred
authors.initials: M
authors.lastname: Gogol
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D004791:Enzyme Inhibitors